Successful desensitization for cytarabine-induced anaphylaxis: The first documented case report in Vietnam
Abstract
The chemotherapeutic agent cytarabine is an uncommon cause of anaphylaxis. According to the World Allergy Organization, the diagnosis of anaphylaxis is primarily based on clinical symptoms, while biomarkers play a supporting role. However, in some cases, the underlying factors are complex and challenging to identify, especially in countries that lack the laboratory capacity to perform specialized tests. Drug desensitization – the temporary induction of tolerance to a sensitized drug – is the optimal approach when no alternative drug is available; however, desensitization is not always successful. Adjusting the desensitization protocol by extending the duration of each step or intensifying premedication drugs is the proposed solution to address this problem. To date, there have been few reports about cytarabine desensitization. We report the case of a 31-year-old male with acute myeloid leukemia (AML-M2) who developed severe anaphylaxis during his fourth course of high-dose cytarabine. An initial 13-step desensitization protocol failed at step 12. Consequently, a revised protocol was implemented, featuring intensified anaphylaxis premedication – including hydrocortisone, montelukast, and levocetirizine administered 3 days before and during the procedure. This modified approach successfully induced temporary tolerance, allowing the patient to complete the required 3,000 mg/day dose without further adverse reactions. This is the first reported case of successful cytarabine…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Artificial Intelligence in Medicine: Cross-Sectional Study Among Medical Students on Application, Education, and Ethical Aspects
- Information quality of videos related to esophageal cancer on tiktok, kwai, and bilibili: a cross-sectional study
- The quality and reliability of short videos about hypertension on TikTok: a cross-sectional study
- Quality and reliability evaluation of pancreatic cancer-related video content on social short video platforms: a cross-sectional study
- Quality and reliability of pediatric pneumonia related short videos on mainstream platforms: cross-sectional study
- Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007–2018
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.